In the company’s news yesterday,
Patriot Scientific Corp. announced that Roper Industries, Sarasota, Florida, (NYSE:ROP) has purchased a Moore Microprocessor Patent(TM) (MMP) Portfolio license from the TPL Group, Patriot Scientific’s exclusive MMP licensing partner.
The portfolio patents cover techniques that allow for higher performance and lower cost microprocessor designs, and are fundamental to consumer and commercial digital systems ranging from DVD players, cell phones and portable music players to communications infrastructure, medical equipment and automobiles.
“Roper Industries joins an expanding list of global industry leaders, including Nokia, Sharp, Hewlett Packard, Fujitsu, Sony, Robert Bosch and other major corporations that have become MMP licensees within the last three years,” commented Rick Goerner, Patriot Scientific President and CEO. “Roper Industries is a further example of the wide range of products that can benefit from an MMP Portfolio license.”
About QualityStocks
QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their advertising efforts and now has over 750,000+ subscribers that receive The Daily Stock Newsletters.
Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net
Forward-Looking Statement:
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.
